Keywords: merck, co, file, mk-0431a, fda, drugmaker, says

Merck & Co to file MK-0431A with FDA in 2006

Article | 12 June 2006

Print This

US drugmaker Merck & Co says that it anticipates submitting its developmental drug MK-0431A, an oral treatment for type 2 diabetes ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in